ZA989206B - Oromucosal cytokine compositions and uses thereof - Google Patents

Oromucosal cytokine compositions and uses thereof

Info

Publication number
ZA989206B
ZA989206B ZA989206A ZA989206A ZA989206B ZA 989206 B ZA989206 B ZA 989206B ZA 989206 A ZA989206 A ZA 989206A ZA 989206 A ZA989206 A ZA 989206A ZA 989206 B ZA989206 B ZA 989206B
Authority
ZA
South Africa
Prior art keywords
oromucosal
cytokine compositions
cytokine
compositions
oromucosal cytokine
Prior art date
Application number
ZA989206A
Other languages
English (en)
Inventor
Michael Gerard Tovey
Original Assignee
Pharma Pacific Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Pacific Pty Ltd filed Critical Pharma Pacific Pty Ltd
Publication of ZA989206B publication Critical patent/ZA989206B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA989206A 1997-10-10 1998-10-08 Oromucosal cytokine compositions and uses thereof ZA989206B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9712687A FR2769505B1 (fr) 1997-10-10 1997-10-10 Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations

Publications (1)

Publication Number Publication Date
ZA989206B true ZA989206B (en) 1999-04-12

Family

ID=9512087

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA989206A ZA989206B (en) 1997-10-10 1998-10-08 Oromucosal cytokine compositions and uses thereof

Country Status (15)

Country Link
EP (1) EP1027068B1 (es)
CN (1) CN1259104C (es)
AR (1) AR015956A1 (es)
AT (1) ATE313331T1 (es)
AU (1) AU762360B2 (es)
CA (1) CA2312906A1 (es)
DE (1) DE69832902T2 (es)
ES (1) ES2252859T3 (es)
FR (1) FR2769505B1 (es)
HK (1) HK1030150A1 (es)
IL (1) IL136604A0 (es)
NZ (1) NZ504955A (es)
TW (1) TWI233357B (es)
WO (1) WO1999018992A1 (es)
ZA (1) ZA989206B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
GB0001710D0 (en) * 2000-01-25 2000-03-15 Pharma Pacific Pty Ltd Therapeutic treatment
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
EP1250933A1 (en) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Vaccines including as an adjuvant high dose type I IFN
CA2823468A1 (en) 2003-04-23 2004-11-04 Medarex, L.L.C. Compositions and methods for the therapy of inflammatory bowel disease
PL1781705T3 (pl) 2004-06-21 2015-03-31 Squibb & Sons Llc Antyciała receptora interferonów alfa I oraz ich zastosowania
AU2008226337B2 (en) * 2007-03-14 2012-02-16 BioLingus IP II GmbH Method for treating cancer via the mucosal administration of interleukin
DE102007014752A1 (de) 2007-03-28 2008-10-02 Dusek, Niels, Dr. Verwendung von humanidentischem oder humanaequivalentem rekombinantem Interleukin-2 (heqlL-2) als Therapeutikum in der Human- und Veterinärmedizin
CN102462837B (zh) * 2010-11-19 2016-08-03 生物林格斯Ip有限公司 抗炎组合物
KR102220006B1 (ko) 2011-03-11 2021-02-24 아시스땅스 퍼블리끄-오삐또 드 빠리 자가면역 - 관련 또는 염증성 장애를 치료하기 위한 저용량 ｉｌ­２ 의 용도
ES2811624T3 (es) 2011-03-11 2021-03-12 Hopitaux Paris Assist Publique Régimen de dosificación de IL-2 para tratar lupus eritematoso sistémico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286748A (en) * 1981-01-05 1994-02-15 Eby Iii George A General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
US5215741A (en) * 1990-10-30 1993-06-01 Amarillo Cell Culture Company, Incorporated Method for prevention of parasite infections
CA2098726A1 (en) * 1990-12-19 1992-06-20 Edward J. Rozhon Use of il-4 to enhance immune response to immunogens in vaccines
EP0578823B1 (en) * 1991-04-08 2002-01-23 Sumitomo Pharmaceuticals Company, Limited Porous solid preparation containing physiologically active protein substance
AU1748697A (en) * 1996-01-19 1997-08-11 Mcgill University Hepatitis pretreatment composition and method

Also Published As

Publication number Publication date
AU762360B2 (en) 2003-06-26
CN1259104C (zh) 2006-06-14
FR2769505B1 (fr) 2000-06-30
WO1999018992A1 (en) 1999-04-22
AU9455698A (en) 1999-05-03
CN1281368A (zh) 2001-01-24
DE69832902T2 (de) 2006-08-10
CA2312906A1 (en) 1999-04-22
HK1030150A1 (en) 2001-04-27
IL136604A0 (en) 2001-06-14
NZ504955A (en) 2002-11-26
DE69832902D1 (de) 2006-01-26
FR2769505A1 (fr) 1999-04-16
ATE313331T1 (de) 2006-01-15
ES2252859T3 (es) 2006-05-16
EP1027068A1 (en) 2000-08-16
AR015956A1 (es) 2001-05-30
TWI233357B (en) 2005-06-01
EP1027068B1 (en) 2005-12-21

Similar Documents

Publication Publication Date Title
HUP0001401A2 (en) Lyme combination compositions and uses
HK1019774A1 (en) Etching composition and use thereof.
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0103562A3 (en) Novel compositions and use
HK1033653A1 (en) Synergistic composition and use thereof
GB9717598D0 (en) Novel composition and use
AU2972597A (en) Compositions and uses thereof
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
EP1113815A4 (en) IMMUNOGENIC COMPOSITIONS AND USES THEREOF
HK1030150A1 (en) Oromucosal cytokine compositions and uses thereof
EP1036165A4 (en) HUMAN RNASE, COMPOSITIONS AND USES THEREOF
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
SG71754A1 (en) Copolymer and copolymer composition
HUP9800596A3 (en) Antifungal compositions and use thereof
AP9901675A0 (en) Pharmaceutical compositions or tizoxanide and nitazoxanide
PL330820A1 (en) Novel radiopharmaceutic compositions and matrices and their application
GB9608505D0 (en) Compositions processes and uses
GB9718636D0 (en) Novel composition and use
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
SG100797A1 (en) Semiconductive ceramic composition and semiconductive ceramic element using the same
AP2002002429A0 (en) Novel composition and emulsifier
AU2164400A (en) Flint compositions and uses thereof
GB9722392D0 (en) Composition and use
GB9706758D0 (en) Compositions and their use
GB9722390D0 (en) Composition and use